Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CpG DNA as a vaccine adjuvant.

Dennis M Klinman1

  • 1Section of Retroviral Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA. Klinman@CBER.FDA.GOV

Expert Review of Vaccines
|August 6, 2003
PubMed
Summary

Synthetic oligodeoxynucleotides with CpG motifs act as powerful immune adjuvants, significantly boosting antibody responses. These CpG DNA molecules enhance vaccine efficacy and are safe for human use in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TLR Agonist Therapy of Metastatic Breast Cancer in Mice.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2023
Same author

Gene network landscape of mouse splenocytes reveals integrin complex as the A151 ODN-responsive hub molecule in the immune transcriptome.

Molecular therapy. Nucleic acids·2023
Same author

Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.

Gut·2021
Same author

Cytosolic d-type CpG-oligonucleotides induce a type I interferon response by activating the cGAS-STING signaling pathway.

European journal of immunology·2021
Same author

The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation.

Scientific reports·2020

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Unmethylated CpG motifs in synthetic oligodeoxynucleotides function as potent immune adjuvants.
  • CpG DNA stimulates T-helper 1 and pro-inflammatory cytokine production.
  • CpG DNA promotes the maturation and activation of antigen-presenting cells like macrophages and dendritic cells.

Purpose of the Study:

  • To evaluate the adjuvant properties of synthetic oligodeoxynucleotides containing unmethylated CpG motifs.
  • To assess the impact of CpG DNA on antigen-specific antibody responses.
  • To determine the safety and efficacy of CpG DNA as a vaccine adjuvant in preclinical and clinical settings.

Main Methods:

  • Coadministration of CpG DNA with immunogens.
  • Assessment of antigen-specific antibody production.
  • Evaluation of cytokine profiles and antigen-presenting cell activation.
  • Preclinical animal challenge models and human clinical studies.

Main Results:

  • CpG DNA significantly accelerated and boosted antigen-specific antibody responses, up to 500-fold.
  • CpG DNA enhanced the production of T-helper 1 and pro-inflammatory cytokines.
  • Close physical contact between CpG DNA and immunogen optimized adjuvant effects.
  • Improved protective immunity was observed in animal models.
  • Clinical studies indicated CpG oligodeoxynucleotides are safe and well-tolerated in humans, often increasing vaccine-induced immune responses.

Conclusions:

  • Synthetic oligodeoxynucleotides containing unmethylated CpG motifs are effective immune adjuvants.
  • CpG DNA enhances vaccine-induced immune responses and protective immunity.
  • CpG DNA demonstrates a favorable safety profile for human adjuvant applications.

Related Experiment Videos